ENDOTIS PHARMA has a total of 23 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Mexico. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are CELGENE INTERNAT SARL, GLYCAN BIOSCIENCES LLC and PHARMASSET INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Mexico | 2 | |
#4 | United States | 2 | |
#5 | Argentina | 1 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | France | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | Republic of Korea | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Sugars | |
#3 | Medical preparations | |
#4 | Polysaccharides | |
#5 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Petitou Maurice | 20 |
#2 | Dubreucq Guy | 10 |
#3 | Querolle Olivier | 10 |
#4 | Zameo Sandrine | 9 |
#5 | Nancy-Portebois Vanessa | 4 |
#6 | Pierdet Pascal | 3 |
#7 | Lewandowski Daniel | 3 |
#8 | Cabannes Eric | 3 |
#9 | Caravano Audrey | 3 |
#10 | Motte Vincent | 3 |
Publication | Filing date | Title |
---|---|---|
WO2013007762A1 | Combination of an anticoagulant and avidin useful in surgical intervention and clinical procedure | |
CN103917552A | Synthetic pentasaccharides having short half-life and high activity | |
FR2974478A1 | OLIGOSACCHARIDE CONJUGATES IN PREVENTION OF ISCHEMIA-REPERFUSION LESIONS | |
EP2512448A2 | Pharmaceutical oral dosage form containing a synthetic oligosaccharide | |
MX2010011428A | Use of oligosaccharide conjugate for the prevention of blood clotting during cardiopulmonary bypass. | |
WO2010029185A1 | Oligosaccharide compounds for use in mobilising stem cells | |
EP1908768A1 | Anticoagulant compounds | |
EP1886696A1 | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |